Article Details

Mayne Pharma's 2H19 YTD revenue dips 15% amidst high competition

Retrieved on: 2019-05-14 13:37:30

Tags for this article:

Click the tags to see associated articles and topics

Mayne Pharma's 2H19 YTD revenue dips 15% amidst high competition. View article details on hiswai:

Excerpt

<div>With a market capitalisation of ~ AUD 894.36 million, the MYX stock is ... to $9.5 in 2017, according to <b>Arcview Market Research</b> and BDS Analytics.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo